Federal award
TOYON RESEARCH CORPORATION
FA865121C0037
Contract
Obligated and Ceiling
- Obligated (net)
- $2,899,991.90
- Ceiling (potential value, not spending)
- $2,899,991.90
- Current value
- $2,899,991.90
- Gross positive obligations
- $2,899,991.90
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TOYON RESEARCH CORPORATION · PK1CB3L39XX8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TOYON RESEARCH CORPORATION · PK1CB3L39XX8
- Awarding agency
- Department of War · sub-agency 5700 · office FA8651
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- AC12 · NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- FA865121C0037
- Award type code
- D
- Actions
- 8 · Sep 30, 2021 to Nov 14, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 14, 2024 | FY2025 | P00007 | C | $497,835.00 | — |
| May 15, 2024 | FY2024 | P00006 | A | $602,165.00 | — |
| Apr 7, 2023 | FY2023 | P00005 | B | $499,992.00 | — |
| Feb 9, 2023 | FY2023 | P00004 | B | $0.00 | — |
| Dec 5, 2022 | FY2023 | P00003 | A | $999,999.90 | — |
| Nov 3, 2021 | FY2022 | P00002 | C | $107,160.00 | — |
| Oct 5, 2021 | FY2022 | P00001 | B | $0.00 | — |
| Sep 30, 2021 | FY2021 | 0 | — | $192,840.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.